Track the NextCell Pharma AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, NextCell Pharma AB has logged 10 insider filings. Market capitalisation: €109.7m. The latest transaction was reported on 3 June 2025 (Other). Among the most active insiders: Patrik Fagerholm. Every trade is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€1,196
3 ops.
Buy Volume
€93,715
1 ops.
Sell Volume
42Σ signal
Buys €1,196€93,715 Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
60,000 shares@ SEK 15.80100.0% of flowAktieISINISIN SE0009723125FI:A001P854-1
10 of 10 declarations
About NextCell Pharma AB
NextCell Pharma AB is a biotechnology company focused on developing cell therapies for the treatment of type 1 diabetes. It is listed on the Stockholm Stock Exchange (XSTO).